Welcome to our dedicated page for Buda Juice SEC filings (Ticker: BUDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Buda Juice, Inc. (BUDA) SEC filings page on Stock Titan is intended to provide access to the company’s regulatory disclosures as they become available through the U.S. Securities and Exchange Commission’s EDGAR system. Buda Juice is a beverage company focused on the UltraFresh™ juice category, supplying always-cold, freshly crafted juices, lemonades, and wellness shots to grocery retailers via an end-to-end cold chain platform.
Buda Juice filed a registration statement on Form S-1 in connection with its initial public offering of common stock and listing on the NYSE American exchange under the ticker symbol BUDA. Over time, investors can expect the company’s key periodic and transactional filings, such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, to appear in this section once they are filed with the SEC.
As filings are added, Stock Titan’s tools can help readers review the information disclosed by Buda Juice, including details about its UltraFresh™ juice operations, production capacity plans, and capital raised through public offerings as described in its registration materials. Users can also look for ownership and insider transaction reports on forms such as Form 3 and Form 4, which provide insight into equity holdings and changes reported by company insiders.
This page updates as new Buda Juice filings are released by the SEC, allowing investors and researchers to track the company’s regulatory history and disclosures related to its UltraFresh™ beverage business and public listing on the NYSE American exchange.
BUDA JUICE, INC. director Short Donald Wilson filed an initial ownership report showing beneficial ownership of 76,789 shares of restricted common stock. These shares are held directly and were granted under the company’s 2025 Equity Incentive Plan, with no separate buy or sell transaction reported.
Buda Juice, Inc. Chief Financial Officer Clint Lee Bowers reported his initial ownership in the company’s common stock. The filing shows he directly holds 113,100 shares of restricted common stock, granted under the company’s 2025 Equity Incentive Plan.
BUDA JUICE, INC. director and more than 10% owner Herr Bryan Clements has reported his initial holdings on a Form 3. As of January 9, 2026, he directly holds 2,644,466 shares of common stock, including 188,500 shares of restricted common stock granted under the 2025 Equity Incentive Plan.
BUDA JUICE, INC. director and more than ten percent owner Bernard Lucien Nussbaumer filed an initial ownership report showing he directly holds 2,904,860 shares of the company’s common stock as of 2026-01-09. This Form 3 does not reflect any new buy or sell transaction, only existing holdings.
Buda Juice, Inc. reported that Public Ventures, LLC (doing business as MDB Capital), the underwriter of its initial public offering, fully exercised its over-allotment option on January 21, 2026. This option exercise led the company to sell an additional 399,999 shares of common stock.
As a result, Buda Juice received additional gross proceeds of $2,999,992.50 before underwriting discounts, commissions, and offering expenses. This increases the cash raised from its IPO, providing more capital for the company following its recent market debut.
Grow Funds LLC filed a Schedule 13G showing it beneficially owns 945,676 shares of Buda Juice, Inc. common stock, representing about 7.23% of the outstanding class.
Grow Funds reports sole power to vote these shares, with no shared voting or dispositive power, and certifies that the position is held without the purpose or effect of changing or influencing control of the company.
Buda Juice, Inc. reported that it entered into an underwriting agreement for its initial public offering of 2,666,667 common shares at $7.50 per share, for gross proceeds of $20 million before fees and expenses. The underwriters received warrants to purchase 266,667 shares at an exercise price of $9.375 per share, exercisable from July 7, 2026 until January 7, 2031.
The company also adopted the Buda Juice, Inc. 2025 Equity Incentive Plan to grant equity- and cash-based awards to employees, directors, and consultants. Buda Juice issued press releases announcing the IPO pricing and the start of trading of its common stock on the NYSE American exchange.